Works matching DE "MOLNUPIRAVIR"

Results: 187
    1
    2
    3
    4
    5

    A study survey on molnupiravir treatment in COVID-19 patients at home in Ninh Thuan province, Vietnam.

    Published in:
    European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 1, p. 433
    By:
    • LE-HUY, T.;
    • BALZANELLI, M. G.;
    • THAI-PHUONG, P.;
    • TRAN THAI, T.;
    • VU NGOC, H. NGUYEN;
    • TRAN PHUC, L.;
    • LE QUOC, T.;
    • NGUYEN THANH, T.;
    • NAI THANH, T.;
    • LE VAN, T.;
    • THI BICH, L. P.;
    • LAZZARO, R.;
    • DISTRATIS, P.;
    • DIPALMA, G.;
    • MOROLLA, R.;
    • INCHINGOLO, A. M.;
    • DONGIOVANNI, L.;
    • TRIGGIANO, F.;
    • SANTACROCE, L.;
    • DEL PRETE, R.
    Publication type:
    Article
    6
    7

    Molnupiravir is effective in patients with haematological malignancies.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 6, p. 1251, doi. 10.1002/ijc.34442
    By:
    • Bołkun, Łukasz;
    • Pula, Bartosz;
    • Kołkowska‐Leśniak, Agnieszka;
    • Morawska, Marta;
    • Cichocka, Edyta;
    • Charlinski, Grzegorz;
    • Garus, Bartosz;
    • Giebel, Sebastian;
    • Piszcz, Jaroslaw;
    • Drozd‐Sokolowska, Joanna;
    • Kwiatkowski, Jacek;
    • Biernat, Monika;
    • Hus, Iwona;
    • Lech‐Maranda, Ewa;
    • Długosz‐Danecka, Monika;
    • Giannopoulos, Krzysztof;
    • Wróbel, Tomasz
    Publication type:
    Article
    8

    Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34839-9
    By:
    • Donovan-Banfield, I'ah;
    • Penrice-Randal, Rebekah;
    • Goldswain, Hannah;
    • Rzeszutek, Aleksandra M.;
    • Pilgrim, Jack;
    • Bullock, Katie;
    • Saunders, Geoffrey;
    • Northey, Josh;
    • Dong, Xiaofeng;
    • Ryan, Yan;
    • Reynolds, Helen;
    • Tetlow, Michelle;
    • Walker, Lauren E.;
    • FitzGerald, Richard;
    • Hale, Colin;
    • Lyon, Rebecca;
    • Woods, Christie;
    • Ahmad, Shazaad;
    • Hadjiyiannakis, Dennis;
    • Periselneris, Jimstan
    Publication type:
    Article
    9

    SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32045-1
    By:
    • Lieber, Carolin M.;
    • Cox, Robert M.;
    • Sourimant, Julien;
    • Wolf, Josef D.;
    • Juergens, Kate;
    • Phung, Quynh;
    • Saindane, Manohar T.;
    • Smith, Meghan K.;
    • Sticher, Zachary M.;
    • Kalykhalov, Alexander A.;
    • Natchus, Michael G.;
    • Painter, George R.;
    • Sakamoto, Kaori;
    • Greninger, Alexander L.;
    • Plemper, Richard K.
    Publication type:
    Article
    10
    11
    12
    13
    14

    Molnupiravir.

    Published in:
    Australian Prescriber, 2022, v. 45, n. 2, p. 60, doi. 10.18773/austprescr.2022.014
    Publication type:
    Article
    15

    Erratum.

    Published in:
    2023
    Publication type:
    Correction Notice
    16
    17
    18
    19
    20
    21

    Non-randomized evaluation of hospitalization after a prescription for nirmatrelvir/ritonavir versus molnupiravir in high-risk COVID-19 outpatients.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 7, p. 1683, doi. 10.1093/jac/dkad154
    By:
    • Cowman, Kelsie;
    • Miller, Alexander;
    • Guo, Yi;
    • Chang, Mei H;
    • McSweeney, Terrence;
    • Bao, Hongkai;
    • Simpson, Roxanne;
    • Braithwaite, Claire;
    • Sunu, Evans;
    • Ros, Theary;
    • Rodriguez, Maria;
    • Laboy, Eric;
    • Bard, Linda;
    • Alsina, Leslie;
    • Cintron, Angelica;
    • Andrews, Erin;
    • Nori, Priya
    Publication type:
    Article
    22
    23
    24
    25

    A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients.

    Published in:
    Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04322-8
    By:
    • Alteri, Claudia;
    • Fox, Valeria;
    • Scutari, Rossana;
    • Burastero, Giulia Jole;
    • Volpi, Sara;
    • Faltoni, Matteo;
    • Fini, Vanessa;
    • Granaglia, Annarita;
    • Esperti, Sara;
    • Gallerani, Altea;
    • Costabile, Valentino;
    • Fontana, Beatrice;
    • Franceschini, Erica;
    • Meschiari, Marianna;
    • Campana, Andrea;
    • Bernardi, Stefania;
    • Villani, Alberto;
    • Bernaschi, Paola;
    • Russo, Cristina;
    • Guaraldi, Giovanni
    Publication type:
    Article
    26
    27

    A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 628, p. 1, doi. 10.1126/scitranslmed.abl7430
    By:
    • Fischer II, William A.;
    • Eron Jr, Joseph J.;
    • Holman, Wayne;
    • Cohen, Myron S.;
    • Fang, Lei;
    • Szewczyk, Laura J.;
    • Sheahan, Timothy P.;
    • Baric, Ralph;
    • Mollan, Katie R.;
    • Wolfe, Cameron R.;
    • Duke, Elizabeth R.;
    • Azizad, Masoud M.;
    • Borroto-Esoda, Katyna;
    • Wohl, David A.;
    • Coombs, Robert W.;
    • James Loftis, Amy;
    • Alabanza, Paul;
    • Lipansky, Felicia;
    • Painter, Wendy P.
    Publication type:
    Article
    28
    29
    30
    31
    32

    Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study.

    Published in:
    Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00376-4
    By:
    • Tomida, Takeshi;
    • Kimura, Takeshi;
    • Yamamoto, Kazuhiro;
    • Uda, Atsushi;
    • Matsumoto, Yuki;
    • Tamura, Naoki;
    • Iida, Masashi;
    • Tanifuji, Akiko;
    • Matsumoto, Kumiko;
    • Mizuta, Naomi;
    • Ebisawa, Kei;
    • Ohji, Goh;
    • Omura, Tomohiro;
    • Iwata, Kentaro;
    • Yano, Ikuko
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40

    Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

    Published in:
    Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2715, doi. 10.1007/s10238-022-00949-3
    By:
    • Suzuki, Yasuhito;
    • Shibata, Yoko;
    • Minemura, Hiroyuki;
    • Nikaido, Takefumi;
    • Tanino, Yoshinori;
    • Fukuhara, Atsuro;
    • Kanno, Ryuzo;
    • Saito, Hiroyuki;
    • Suzuki, Shuzo;
    • Inokoshi, Yayoi;
    • Sando, Eiichiro;
    • Sakuma, Hirofumi;
    • Kobayashi, Tatsuho;
    • Kume, Hiroaki;
    • Kamimoto, Masahiro;
    • Aoki, Hideko;
    • Takama, Akira;
    • Iizuka, Taku;
    • Kamiyama, Takamichi;
    • Nakayama, Masaru
    Publication type:
    Article
    41
    42

    Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir.

    Published in:
    Toxicological Sciences, 2024, v. 202, n. 2, p. 278, doi. 10.1093/toxsci/kfae112
    By:
    • Escobar, Patricia A;
    • Sobol, Zhanna;
    • Miller, Randy R;
    • Ferry-Martin, Sandrine;
    • Stermer, Angela;
    • Jacob, Binod;
    • Muniappa, Nagaraja;
    • Sanchez, Rosa I;
    • Blanchard, Kerry T;
    • Galijatovic-Idrizbegovic, Alema;
    • Amin, Rupesh P;
    • Troth, Sean P
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50